Despite these established differences, most FSHD myoblasts are indistinguishable in their transcription profile when compared to non-FSHD control myoblasts including the lack of differences in expression of DUX4 and its downstream targets [13]. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.